Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-03-04 @ 1:39 PM
Study NCT ID:
NCT06651593
Status:
RECRUITING
Last Update Posted:
2025-08-15
First Post:
2024-10-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors
Sponsor:
Organization: